Coya Therapeutics, Inc. · NASDAQ:COYA
DME Capital Management, LP reported a 9.90% stake in Coya Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
DME Capital Management, LP reported a 9.90% stake in Coya Therapeutics, Inc., 1,651,440 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 1,651,440
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| DME Capital Management, LP | 7.60% | 1,267,669 |
| DME Advisors, LP | 2.30% | 383,771 |
| DME Advisors GP, L.L.C. | 9.90% | 1,651,440 |
| EINHORN DAVID | 9.90% | 1,651,440 |
Source
Related
- Coya Therapeutics, Inc.
- DME Capital Management, LP
- Coya Therapeutics, Inc. shareholders
- Schedule 13G/A · Orin Hirschman · Jul 27, 2026
- Schedule 13G · Dr. Reddy's Laboratories, Inc. · Mar 12, 2026
- Schedule 13G/A · The Vanguard Group · Jan 30, 2026
- Schedule 13G/A · Orin Hirschman · Jan 28, 2026
- Schedule 13G/A · Orin Hirschman · Feb 10, 2025